News on

general informations  
Project acronym: SARSVAC
Project full title: Immunoprevention and immunotherapy of SARS infection
Contract no.: SP22-CT-2004-511065
Project Coordinator: Konrad Stadler, Novartis Vaccines and Diagnostics Srl - Siena, Italy
EC Contribution: 1.200.000 Euro
Starting date: March 1, 2004
Duration: 3 years
Participants: 4 from 4 countries:
Novartis Vaccines and Diagnostics Srl, ITALY
Philipps-Universität-Marburg, GERMANY
Institute for Research in Biomedicine, SWITZERLAND
Fudan University, CHINA